The trajectory of the erectile dysfunction drug presents a complex picture for shareholders. While the initial introduction generated massive gains, the lapse of its exclusive rights opened the door to generic https://iwancekc790756.blogzet.com/sildenafil-and-pharma-a-risky-investment-56911332